Multimodal Imaging in Central Serous Chorioretinopathy

Central Serous Chorioretinopathy Clinical Trial

— IMO  

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT02889185
• Other study ID #: P/2015/249
• Status: Terminated
• Phase: N/A
• Start date: April 2016
• Est. completion date: December 4, 2018

Study information

• Verified date: September 2019
• Source: Centre Hospitalier Universitaire de Besancon
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study aims to assess the contribution of the multimodal imaging, combining a routine examination using Optical Coherence Tomography (OCT) with an imaging procedure using adaptive optics retinal camera.

This is a feasibility study with a limited number of patients.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 3
• Est. completion date: December 4, 2018
• Est. primary completion date: December 4, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 60 Years

Eligibility

Inclusion Criteria:

• Signed informed consent form

• Beneficiary/affiliated to French social security/social healthcare

• Active ou chronic Central Serous Chorioretinopathy on at least one eye

• Absence of other known ophthalmological pathology or of any ophthalmological conditions revealed during the examination

Exclusion Criteria:

• Legal incapacity or limited legal capacity

• Predictable poor adherence

• Subject without health insurance

• Pregnant or breatfeeding women

• Sujet étant dans la période d'exclusion d'une autre étude ou prévue par le "fichier national des volontaires"

• Presence of transparent medium opacity damaging images quality

• Previous photosensitivity

• Recent treatment with PhotoDynamic Therapy (PDT)

• Use of drugs inducing photosensitivity

Related Conditions & MeSH terms

• Central Serous Chorioretinopathy

Intervention

Device:
• RTX1 IMAGIN EYE retinal camera
In addition to the routine examination including OCT, an imaging using RTX1 IMAGIN EYE retinal camera will be performed.

Locations

Country	Name	City	State
France	CHU Besançon	Besançon

Sponsors (1)

Lead Sponsor	Collaborator
Centre Hospitalier Universitaire de Besancon

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Workability of images of RTX1 IMAGIN EYE retinal camera	Two readings of the images captured with adaptative optics retinal camera and assessment of their workability in routine care.	day 1